The Pharmaceutical Journal
Vol 270 No 7237 p260
22 February 2003

This article
Reprint
Photocopy

News summary

Related websites
Advisory Council on the Misuse of Drugs (more)

GHB reclassification

Gamma-hydroxybutyrate (GHB) is to be reclassified as a Class C Controlled Drug by the early summer (our Lobby correspondent writes). The Government has accepted a recommendation from the Advisory Council on the Misuse of Drugs to control the drug, and regulations will be laid before Parliament in the next few weeks.